Is Hybrid Operating Room Necessary for Safe TAVR

According to this sub-study of the FRANCE TAVI registry, mortality is similar for transcatheter aortic valve replacement in hybrid operating rooms vs. conventional catheterization labs. These findings support performing TAVR in conventional cath labs, which goes hand in hand with TAVR expansion, with improved logistics and organization costs.

This study compared outcomes of patients undergoing TAVR in conventional cath labs vs. TAVR in hybrid ORs. The latter sounds ideal should complications arise, but hybrid ORs are scarce, costly and they involve a complicated logistic that might not be worth the while. A hybrid operating room does not make much sense without a cardiovascular surgeon in hand, and surgeons always have assistants, surgical technologists, attendings, etc., hence the complicated logistic, which in turn entails higher costs.

 

Indeed, for TAVR, as opposed to PCI, there should be heart surgery backup.


Read also: Promising Results for Tricuspid Repair.


All TAVR procedures done in 48 centers in France between January 2013 and December 2015 were retrospectively included in the France TAVI registry (French Transcatheter Aortic Valve Implantation). Primary end point was all cause mortality at one year. 30-day and 3-year mortality were considered secondary end points.

 

A total 12121 patients were included in the study, 62% received the procedure in conventional cath labs and 38% in Hybrid ORs. Baseline characteristics were similar between the groups.

 

Both groups showed a similar complications rate, below 2%. After multiple adjustments, major bleeding and infections were higher in the hybrid OR group (bleeding 6.3% vs. 4.8%; infections 6.1% vs. 3.5%; p<0.05), surprisingly, since we would expect exactly the opposite as regards infections.


Read also: Angiography Guided CABG Still Adequate.


Adjusted mortality at 1 and 3 years did not result different between the groups (cath lab 16.2% vs. hybrid OR 15.8% at 1 year, p=0.91 and 38.4%; vs 36.4%, p=0.49 at 3 years, respectively).

 

Conclusion

Mortality at 1 and 3 years is similar between patients undergoing TAVR in a conventional cath lab vs. a hybrid OR.

 

Título original: Transcatheter Aortic Valve Replacement in the Catheterization Laboratory Versus Hybrid Operating Room. Insights from the FRANCE TAVI Registry.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...